| Medtronic to launch new phase II trial of renal nerve ablation (Symplicity device) |
|
| St. Paul / Minneapolis Business Journal: Medtronic Inc.'s Symplicity system, designed to treat high blood pressure in patients, took a blow last year when it flubbed a clinical trial. But the company is poised to launch another trial this year. |